Records were reviewed retrospectively for all patients treated at a single tertiary cancer center for classical HL from 2003 through 2013. Inclusion criteria included Ann Arbor stage I or II disease, age of ≥18 years at the time of diagnosis, and availability of an analyzable pre-chemotherapy PET-CT scan. Patients with a disease volume measuring <5 cc were excluded.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.